UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

update on the genotoxicity and carcinogenicity of marketed pharmaceuticals with reference to in silico predictivity

Environmental and molecular mutagenesis, 2009-07, Vol.50 (6), p.435-450

Snyder, Ronald D

2009

Volltextzugriff (PDF)

Assessment of atypical DNA intercalating agents in biological and in silico systems

Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis, 2007-10, Vol.623 (1), p.72-82

Snyder, Ronald D.

2007

Volltextzugriff (PDF)

Validation of putative genomic biomarkers of nephrotoxicity in rats

Toxicology (Amsterdam), 2008-04, Vol.246 (2), p.91-100

2008

Volltextzugriff (PDF)

Genetic toxicology in the 21st century: Reflections and future directions

Environmental and molecular mutagenesis, 2011-06, Vol.52 (5), p.339-354

2011

Volltextzugriff (PDF)

Possible structural and functional determinants contributing to the clastogenicity of pharmaceuticals

Environmental and molecular mutagenesis, 2010-10, Vol.51 (8-9), p.800-814

Snyder, Ronald D.

2010

Volltextzugriff (PDF)

A review of the genotoxicity of marketed pharmaceuticals

Mutation Research-Reviews in Mutation Research, 2001-05, Vol.488 (2), p.151-169

2001

Volltextzugriff (PDF)

Toxicogenomics in drug discovery and development: mechanistic analysis of compound/class-dependent effects using the DrugMatrix database

Pharmacogenomics, 2006-10, Vol.7 (7), p.1025-1044

2006

Volltextzugriff (PDF)

Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody–associated vasculitis

Arthritis & rheumatology (Hoboken, N.J.), 2011-12, Vol.63 (12), p.3988-3997

2011

Volltextzugriff (PDF)

In Vitro Detection of Drug-Induced Phospholipidosis Using Gene Expression and Fluorescent Phospholipid–Based Methodologies

Toxicological sciences, 2007-09, Vol.99 (1), p.162-173

2007

Volltextzugriff (PDF)

Characterization and Interlaboratory Comparison of a Gene Expression Signature for Differentiating Genotoxic Mechanisms

Toxicological sciences, 2009-08, Vol.110 (2), p.341-352

2009

Volltextzugriff (PDF)

Emerging approaches in predictive toxicology

Environmental and molecular mutagenesis, 2014-12, Vol.55 (9), p.679-688

2014

Volltextzugriff (PDF)

Clinical outcomes for patients finished with the SureSmile™ method compared with conventional fixed orthodontic therapy

The Angle orthodontist, 2011-05, Vol.81 (3), p.383-388

2011

Volltextzugriff (PDF)

Prediction of noncovalent Drug/DNA interaction using computational docking models: Studies with over 1350 launched drugs

Environmental and molecular mutagenesis, 2013-10, Vol.54 (8), p.668-681

2013

Volltextzugriff (PDF)

Reimagining the Digital Monograph: Design Thinking to Build New Tools for Researchers

Journal of Electronic Publishing, 2018, Vol.21 (1)

2018

Volltextzugriff (PDF)

Resumption of high-dose methotrexate after methotrexate-induced nephrotoxicity and carboxypeptidase G2 use

American journal of health-system pharmacy, 2007-06, Vol.64 (11), p.1163-1169

Snyder, Ronald L

2007

Volltextzugriff (PDF)

Evaluation of the clastogenic, DNA intercalative, and topoisomerase II-interactive properties of bioflavonoids in Chinese hamster V79 cells

Environmental and molecular mutagenesis, 2002, Vol.40 (4), p.266-276

2002

Volltextzugriff (PDF)

Assessment of the sensitivity of the computational programs DEREK, TOPKAT, and MCASE in the prediction of the genotoxicity of pharmaceutical molecules

Environmental and molecular mutagenesis, 2004, Vol.43 (3), p.143-158

2004

Volltextzugriff (PDF)

Toward a greater appreciation of noncovalent chemical/DNA interactions: Application of biological and computational approaches

Environmental and molecular mutagenesis, 2005, Vol.45 (2-3), p.100-105

2005

Volltextzugriff (PDF)

DNA intercalative potential of marketed drugs testing positive in in vitro cytogenetics assays

Mutation research, 2006-10, Vol.609 (1), p.47-59

2006

Volltextzugriff (PDF)

Computational prediction of genotoxicity: room for improvement

Drug discovery today, 2005-08, Vol.10 (16), p.1119-1124

2005

Volltextzugriff (PDF)

Lovastatin enhances the genotoxicity of doxorubicin in Chinese hamster V79 cells via noncovalent DNA binding

Drug and chemical toxicology (New York, N.Y. 1978), 2009, Vol.32 (1), p.17-20

Snyder, Ronald D.

2009

Volltextzugriff (PDF)

Evidence for the contribution of non-covalent steroid interactions between DNA and topoisomerase in the genotoxicity of steroids

Drug and chemical toxicology (New York, N.Y. 1978), 2015-04, Vol.38 (2), p.212-219

2015

Volltextzugriff (PDF)

SFTG international collaborative study on in vitro micronucleus test III. Using CHO cells

Mutation research, 2006-08, Vol.607 (1), p.61-87

2006

Volltextzugriff (PDF)

Reduction of genistein clastogenicity in Chinese hamster V79 cells by daidzein and other flavonoids

Food and chemical toxicology, 2003-10, Vol.41 (10), p.1291-1298

2003

Volltextzugriff (PDF)

Early Events in Vascular Injury in the Rat Induced by the Phosphodiesterase IV Inhibitor SCH 351591

Toxicologic pathology, 2010-08, Vol.38 (5), p.738-744

2010

Volltextzugriff (PDF)

1 – 25 von 1.174

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(925)
Mit Volltextzugriff
(940)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.171)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

update on the genotoxicity and carcinogenicity of marketed pharmaceuticals with reference to in silico predictivity

Assessment of atypical DNA intercalating agents in biological and in silico systems

Validation of putative genomic biomarkers of nephrotoxicity in rats

Genetic toxicology in the 21st century: Reflections and future directions

Possible structural and functional determinants contributing to the clastogenicity of pharmaceuticals

A review of the genotoxicity of marketed pharmaceuticals

Toxicogenomics in drug discovery and development: mechanistic analysis of compound/class-dependent effects using the DrugMatrix database

Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody–associated vasculitis

In Vitro Detection of Drug-Induced Phospholipidosis Using Gene Expression and Fluorescent Phospholipid–Based Methodologies

Characterization and Interlaboratory Comparison of a Gene Expression Signature for Differentiating Genotoxic Mechanisms

Emerging approaches in predictive toxicology

Clinical outcomes for patients finished with the SureSmile™ method compared with conventional fixed orthodontic therapy

Prediction of noncovalent Drug/DNA interaction using computational docking models: Studies with over 1350 launched drugs

Reimagining the Digital Monograph: Design Thinking to Build New Tools for Researchers

Resumption of high-dose methotrexate after methotrexate-induced nephrotoxicity and carboxypeptidase G2 use

Evaluation of the clastogenic, DNA intercalative, and topoisomerase II-interactive properties of bioflavonoids in Chinese hamster V79 cells

Assessment of the sensitivity of the computational programs DEREK, TOPKAT, and MCASE in the prediction of the genotoxicity of pharmaceutical molecules

Toward a greater appreciation of noncovalent chemical/DNA interactions: Application of biological and computational approaches

DNA intercalative potential of marketed drugs testing positive in in vitro cytogenetics assays

Computational prediction of genotoxicity: room for improvement

Lovastatin enhances the genotoxicity of doxorubicin in Chinese hamster V79 cells via noncovalent DNA binding

Evidence for the contribution of non-covalent steroid interactions between DNA and topoisomerase in the genotoxicity of steroids

SFTG international collaborative study on in vitro micronucleus test III. Using CHO cells

Reduction of genistein clastogenicity in Chinese hamster V79 cells by daidzein and other flavonoids

Early Events in Vascular Injury in the Rat Induced by the Phosphodiesterase IV Inhibitor SCH 351591

Suchergebnisse filtern